The recent period end update for Ergomed confirmed the good performance for that was expected for FY2016, with revenues of £38m up 26% year on year, against £35.5m forecast. The company retains its momentum, and with an attractive forward order book currently worth £42m, this could be expected to continue. Our sum-of-the-parts valuation analysis suggests that the Services businesses are valued at c.202p. With the Products businesses added to this, the valuation increases to 301p.
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
2016 revenues ahead of forecasts
- Published:
25 Jan 2017 -
Author:
Elizabeth Klein -
Pages:
2
The recent period end update for Ergomed confirmed the good performance for that was expected for FY2016, with revenues of £38m up 26% year on year, against £35.5m forecast. The company retains its momentum, and with an attractive forward order book currently worth £42m, this could be expected to continue. Our sum-of-the-parts valuation analysis suggests that the Services businesses are valued at c.202p. With the Products businesses added to this, the valuation increases to 301p.